• Diagnosis of Peritoneal Dissemination: Comparison of l8F-FDG PET/CT, Diffusion-Weighted MRI, and Contrast-Enhanced MDCT

    AJR :196, February 2011

    Yoko Satoh, Tomoaki Ichikawa, Utarou Motosugi, Kazufumi Kimura, Hironobu Sou, Katsuhiro Sano, Tsutomu Araki

    OBJECTIVE. The purpose of this study was to compare the diagnostic performance of 18F-FDG PET/CT, MRI with and without diffusion-weighted imaging (DWI), and contrast-enhanced MDCT in the detection of peritoneal dissemination of malignant tumors.

    MATERIALS AND METHODS. We retrospectively evaluated the cases of 107 pa­tients who underwent PET/CT and 130 patients who underwent MRI and contrast-enhanced MDCT. Twenty-six patients who underwent PET/CT and 23 who underwent MRI and con­trast-enhanced MDCT were found to have peritoneal dissemination. All images were inde­pendently evaluated by two radiologists using a 5-point grading system. The results of PET/ CT, Tl- and T2-weighted MRI without DWI, MRI with DWI (b = 1,000 s/mm2), and con­trast-enhanced MDCT were compared patient by patient and lesion by lesion by use of re­ceiver operating characteristics analysis. Sensitivity, specificity, and positive predictive value were calculated and compared by use of the chi-square test.

    RESULTS. Patient by patient, the area under the receiver operating characteristics curve of MRI without DWI (0.88) was significantly less than that of the other modalities (con­trast-enhanced MDCT, 0.91; MRI with DWI, 0.93; PET/CT, 0.97). The sensitivity of PET/ CT (94%) was significantly higher than that of MRI without DWI (70%). The specificities of the modalities were not significantly different. In lesion-by-lesion analysis, MRI without DWI had significantly lower sensitivity (56%) than the other modalities (contrast-enhanced MDCT, 76%; MRI with DWI, 84%; PET/CT, 89%). The positive predictive value of PET/ CT (93%) was significantly higher than that of the other three modalities (contrast-enhanced MDCT, 73%; MRI without DWI, 70%; MRI with DWI, 72%).

    CONCLUSION. PET/CT is the most useful technique for pathologic staging in the care of patients with malignant disease. If PET/CT is not available, DWI can be used as a screening tool.